ArticleInternal medicine (Tokyo, Japan)2023

Successful Pre- and Post-transplant Administration of Gilteritinib in a Patient with Relapsed and Refractory Acute Myeloid Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.

Taro Edahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.